Australia’s ANTG And Canada’s Asterion Cannabis Signal Intention To Merge

Australian Natural Therapeutic Group and Asterion Cannabis

A merger between local medicinal cannabis company Australian Natural Therapeutics Group  (ANTG) and Canada’s Asterion Cannabis Inc. will deliver what is claimed to be the largest renewables-powered medicinal cannabis growing, manufacturing and R&D facility in the world.

The 75 hectare facility near Toowoomba will produce more than 500,000 kg of medicinal cannabis a year and provide an employment bonanza, creating around 1,000 regional jobs. Construction of the first phase, consisting of a 10-hectare glasshouse and manufacturing facility, should kick off in the next few months and be up and running by the end of next year.

CEO of ANTG Matt Cantelo says the venture will help avoid the risk of demand for medical cannabis in Australia exceeding supply.

“We have the gold standard in regulatory framework, depth of research and climate for growing excellent produce – but what we haven’t had to date is the option of scale,” he stated. “Once we get the scale we need, we will be working to ensure medicinal cannabis is more accessible to Australians.”

Advertisement
Hemp Protein

CEO of Asterion Stephen Van Deventer said the merger will provide early revenue for Asterion and scalability to ANTG.

“We are extremely excited with this merger as both companies have the same vision, priorities and mindset.”

Asterion already has a local presence through its wholly owned subsidiary, Asterion Australia. The previously announced Toowoomba project also has the support of the Australian Government, with the venture awarded Major Project Status back in 2019 – but there hadn’t been much further news about the project since until now.

Regarding the merger, a partially binding agreement-Letter of Intent has been signed by both parties; so this isn’t a done deal yet.

ANTG produces four strains of medicinal cannabis flower and in 2019 the company had one its domestically grown cannabis products , EVE Cannabis Indica, listed on the Australian Register of Therapeutic Goods (ARTG). As for Asterion, it holds a medicinal cannabis license, a cannabis research license and a manufacture license in Australia, granted by the Australian Office of Drug Control.